JAMA Clinical Reviews cover image

Update on Peanut Allergy

JAMA Clinical Reviews

00:00

OIT Risks and When to Pause Doses

Abrams reports therapy-related anaphylaxis (~14–15%), advises holding doses during illness or uncontrolled asthma.

Play episode from 13:51
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app